CBC, or cannabichromene, is a non-psychoactive cannabinoid found in hemp and cannabis, often ranked among the most abundant after CBD and THC. It won't get you high, it comes from the same parent compound as the others, and while early research looks interesting, the human evidence is still thin.
CBC was discovered in 1966, around the same time as CBD. Then it spent the next half-century as an afterthought while THC and CBD got all the attention.
That's a little unfair, because CBC is often one of the most plentiful cannabinoids in the plant. If you've used a full-spectrum hemp product, you've almost certainly taken some without knowing it.
So here's the proper introduction this quiet cannabinoid never quite got: what CBC is, how it works, whether it does anything you'd notice, and where the science honestly stands.
Quick Takeaways
- CBC (cannabichromene) is a non-psychoactive cannabinoid; it does not get you high.
- It comes from CBGA, the same "parent" compound that produces CBD and THC.
- It's often one of the most abundant cannabinoids in the hemp plant.
- Early research (mostly lab and animal) looks at inflammation, pain, mood, and gut health, but human evidence is very limited.
- It's best known for the "entourage effect," working alongside CBD and THC rather than starring on its own.
What Is CBC (Cannabichromene), Exactly?
CBC is a non-psychoactive cannabinoid produced in hemp and cannabis. Like CBD and THC, it starts as CBGA (the plant's "mother cannabinoid") and forms as the plant matures. It's chemically related to the others but behaves differently in the body.
Every major cannabinoid traces back to one source.
CBC begins as cannabigerolic acid (CBGA), which converts into various cannabinoids as the plant grows and meets light, heat, and air. CBD, THC, and CBC are essentially siblings from that same parent.
What makes CBC notable is how common it is. It's frequently cited as one of the most abundant cannabinoids in the plant, even if it's one of the least talked about.
Does CBC Get You High?
No. CBC is non-psychoactive and won't produce a high. Its structure gives it a low affinity for the brain's CB1 receptor, the one responsible for THC's intoxicating effects.

This is the headline reassurance. A feature of CBC's structure reduces its binding to CB1 receptors, the receptors tied to feeling high. So like CBD, CBC sits firmly in the non-intoxicating camp.
No euphoria, no impairment.
How Does CBC Work in the Body?
CBC interacts with the endocannabinoid system, but it leans more on other receptors (like TRPV1 and TRPA1) tied to pain and inflammation. It may also slow the breakdown of the body's own "bliss" compounds, which is part of why it's studied for its effects on mood.
Rather than gripping CB1 the way THC does, CBC works more indirectly. It engages receptors involved in pain and inflammation signaling, and it appears to interact with the body's natural endocannabinoids.
That different mechanism is why CBC's proposed effects don't look identical to CBD's, even though neither gets you high.
What Does the Research Actually Say About CBC?
Early research, mostly in lab and animal models, has explored CBC for inflammation, pain, mood, and even brain-cell growth. The findings are intriguing but preliminary. There isn't enough human evidence to make confident claims yet.
Here's the honest state of play, and it's important to keep the hedges:
| Research area | What's been studied | Evidence so far |
|---|---|---|
| Inflammation and pain | Animal studies on CBC's anti-inflammatory and pain-related effects, including a mouse study on inflammation-driven gut motility. | Preclinical, animal-only |
| Mood | Rodent research examining CBC for mood-related effects. | Early-stage; does not show CBC treats any condition |
| Brain health | A few studies exploring whether CBC supports the growth of certain brain cells. | Promising direction, unproven in people |
| Gut health | CBC studied in digestive-tract models for its effect on motility and inflammation. | Preclinical, model-based |
Despite being discovered in 1966, research on CBC remains extremely limited. Most of what's above is preclinical. So treat CBC as a compound with interesting potential, not a proven remedy for anything.
The Entourage Effect: CBC's Real Day Job
The entourage effect is the idea that cannabinoids work better together than in isolation. CBC is often cited as a team player here, potentially enhancing the effects of CBD and THC rather than doing much dramatic on its own.
This is where CBC most likely earns its keep today. Research suggests cannabinoids can have more pronounced effects alongside their sibling compounds than alone.
That's the whole argument for full-spectrum products: you get CBD plus the supporting cast (CBC, CBG, trace others) working in concert.
So if you take a full-spectrum hemp product, CBC is part of that ensemble even though it never gets top billing.
CBC vs CBD: The Quick Version
Both are non-psychoactive cannabinoids from the same plant, but they engage different receptors and have very different amounts of research behind them. CBD is far better studied; CBC is more of an emerging supporting player.
The short version: CBD is the headliner with the most human research, while CBC is the understudied cousin that may amplify the ensemble.
For the full side-by-side, see CBC vs CBD, and for the cannabinoid that started this whole family tree, our primer on what CBD is is the place to start.
The bottom line
CBC is hemp's quietly abundant cannabinoid: non-psychoactive, born from the same CBGA parent as CBD and THC, and present in most full-spectrum products.
Early lab and animal research into inflammation, pain, mood, and brain health is genuinely interesting, but it's preliminary, and there's no solid human evidence to support firm health claims.
For now, CBC's clearest role is as a team player in the entourage effect, quietly rounding out a full-spectrum blend rather than starring on its own.
Take the edge off
CBD Gummies for Stress
Our #1 full-spectrum CBD gummies for everyday stress, made to quiet the scaries and keep you clear-headed. No high, just calm.
Shop CBD Gummies for Stress Backed by our 100% money-back guarantee.Frequently Asked Questions
Is CBC psychoactive?
No. CBC is non-psychoactive and won't get you high. Its structure gives it low affinity for the CB1 receptor responsible for THC's intoxicating effects.
What is CBC good for?
Early lab and animal research has explored CBC for inflammation, pain, mood, and brain-cell support, but human evidence is very limited. It's best understood as a supporting cannabinoid, not a proven treatment.
Is CBC the same as CBD?
No. Both are non-psychoactive cannabinoids from the same plant and parent compound, but they interact with different receptors, and CBD has far more research behind it. See our CBC vs CBD breakdown for details.
Does CBC show up in full-spectrum products?
Usually, yes. CBC is one of the more abundant cannabinoids in hemp, so full-spectrum products typically contain it as part of the entourage of compounds.
Will CBC make me fail a drug test?
CBC itself isn't what standard drug tests target (they look for THC). However, full-spectrum products contain trace THC, so test risk depends on the product, not CBC specifically.
Want the whole ensemble, not just one note?
Our full-spectrum CBD Gummies for Stress bring CBD and its supporting cannabinoids together, backed by a 100% money-back guarantee.
CBD Gummies for StressThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.